Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Financial Flexibility Index
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥19.91 Million (operating CF CN¥-15.07 Million minus capex CN¥34.98 Million) represents 0% of total liabilities (CN¥2.37 Billion). Check 600513 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Jiangsu Lianhuan Pharmaceutical Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see 600513 operating cash flow.
Annual Financial Flexibility Index for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year free cash flow to debt coverage for Jiangsu Lianhuan Pharmaceutical Co Ltd. Explore debt repayment capacity of Jiangsu Lianhuan Pharmaceutical Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | CN¥195.61 Million | CN¥10.77 Million | CN¥1.44 Billion | ▼ -49.8% |
| 2023 | 0.27x | CN¥361.37 Million | CN¥160.70 Million | CN¥1.34 Billion | ▲ +4.4% |
| 2022 | 0.26x | CN¥336.61 Million | CN¥127.59 Million | CN¥1.30 Billion | ▼ -9.6% |
| 2021 | 0.29x | CN¥307.27 Million | CN¥138.34 Million | CN¥1.07 Billion | ▼ -6.8% |
| 2020 | 0.31x | CN¥266.12 Million | CN¥91.94 Million | CN¥867.05 Million | ▲ +55.7% |
| 2019 | 0.20x | CN¥158.76 Million | CN¥-9.87 Million | CN¥805.57 Million | ▲ +156.6% |
| 2018 | 0.08x | CN¥36.36 Million | CN¥-92.00 Million | CN¥473.43 Million | ▼ -57.9% |
| 2017 | 0.18x | CN¥52.28 Million | CN¥3.64 Million | CN¥286.25 Million | ▼ -62.5% |
| 2016 | 0.49x | CN¥116.50 Million | CN¥70.28 Million | CN¥239.03 Million | ▲ +22.8% |
| 2015 | 0.40x | CN¥89.53 Million | CN¥62.12 Million | CN¥225.66 Million | ▼ -4.0% |
| 2014 | 0.41x | CN¥92.87 Million | CN¥69.50 Million | CN¥224.71 Million | ▲ +50.3% |
| 2013 | 0.27x | CN¥68.02 Million | CN¥37.17 Million | CN¥247.36 Million | ▲ +9.8% |
| 2012 | 0.25x | CN¥23.24 Million | CN¥16.94 Million | CN¥92.79 Million | ▼ -47.0% |
| 2011 | 0.47x | CN¥42.98 Million | CN¥24.00 Million | CN¥90.91 Million | ▲ +133.1% |
| 2010 | 0.20x | CN¥18.69 Million | CN¥8.43 Million | CN¥92.13 Million | ▼ -33.1% |
| 2009 | 0.30x | CN¥27.12 Million | CN¥13.83 Million | CN¥89.47 Million | ▼ -50.4% |
| 2008 | 0.61x | CN¥47.69 Million | CN¥17.44 Million | CN¥77.98 Million | ▲ +142.5% |
| 2007 | 0.25x | CN¥22.11 Million | CN¥8.03 Million | CN¥87.69 Million | ▼ -57.4% |
| 2006 | 0.59x | CN¥45.34 Million | CN¥10.14 Million | CN¥76.64 Million | ▲ +77.6% |
| 2005 | 0.33x | CN¥16.47 Million | CN¥3.82 Million | CN¥49.44 Million | ▲ +137.8% |
| 2004 | 0.14x | CN¥8.63 Million | CN¥3.39 Million | CN¥61.63 Million | ▲ +318.4% |
| 2003 | -0.06x | CN¥-3.01 Million | CN¥-13.19 Million | CN¥46.99 Million | ▼ -110.4% |
| 2002 | 0.61x | CN¥25.19 Million | CN¥19.22 Million | CN¥41.02 Million | — |